Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTX-COVID19-B Booster Vaccination in Adults
NCT05534048Phase 3Withdrawn
- Sponsor
- Everest Medicines
- Start
- Feb 2023
- Primary completion
- Jul 2023
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
01
Overview
A Phase 3 trial of PTX-COVID19-B in Coronavirus Disease 2019 (COVID-19), sponsored by Everest Medicines. Planned start Feb 2023; status: withdrawn.
02
Drugs
PTX-COVID19-B
03
Conditions
Coronavirus Disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05534048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534048.